QTRX
Quanterix Corporation
NASDAQ · Healthcare · Medical - Devices · US
$2.69
+4.26%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 153.3M | 138.7M | 135.4M | 121.1M | 105.5M |
| Cost of Revenue | 87.9M | 73.9M | 54.3M | 48.1M | 60.2M |
| Gross Profit | 65.3M | 64.7M | 81.1M | 73.0M | 45.4M |
| Operating Expenses | |||||
| R&D Expense | 31.9M | 35.9M | 31.1M | 26.1M | 26.8M |
| SG&A Expense | 131.6M | 138.9M | 104.6M | 92.8M | 91.9M |
| General & Admin Expense | 104.3M | 138.9M | 104.6M | 92.8M | 91.6M |
| Selling & Marketing Expense | — | — | — | — | 300.0K |
| Other Expenses | 33.9M | (243.0K) | (2.0M) | 99.0K | 31.0M |
| Total Operating Expenses | 197.5M | 174.5M | 133.7M | 119.0M | 149.6M |
| Cost and Expenses | 285.5M | 248.5M | 188.1M | 167.1M | 209.8M |
| Operating Income (EBIT) | (132.2M) | (109.8M) | (52.6M) | (46.0M) | (104.3M) |
| Non-Operating | |||||
| Interest Income | 4.3M | 8.6M | 14.7M | 15.8M | 5.1M |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 4.3M | 8.6M | 14.7M | 15.8M | 5.1M |
| Other Non-Op Income/Expense | 6.8M | (2.5M) | 14.5M | 18.4M | 4.9M |
| Non-Operating Income (excl Interest) | (6.8M) | 2.5M | (14.5M) | (1.3M) | (31.0M) |
| EBT (Pre-Tax Income) | (125.3M) | (112.3M) | (38.1M) | (27.6M) | (99.4M) |
| Income Tax Expense | (2.2M) | (5.1M) | 434.0K | 719.0K | 164.0K |
| Bottom Line | |||||
| Net Income | (123.1M) | (107.2M) | (38.5M) | (28.4M) | (99.6M) |
| Earnings from Cont. Ops | (123.1M) | (107.2M) | (38.5M) | (28.4M) | (99.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (123.1M) | (107.2M) | (38.5M) | (28.4M) | (99.6M) |
| Per Share | |||||
| Basic EPS | ($2.63) | ($2.51) | ($1.00) | ($0.86) | ($2.61) |
| Diluted EPS | ($2.63) | ($2.51) | ($1.00) | ($0.86) | ($2.61) |
| Revenue Per Share | $3.26 | $3.25 | $3.53 | $3.22 | $2.85 |
| Shares | |||||
| Basic Shares Outstanding | 47.0M | 42.6M | 38.4M | 37.6M | 37.0M |
| Diluted Shares Outstanding | 47.0M | 42.6M | 38.4M | 37.6M | 37.0M |
| Profitability Metrics | |||||
| EBITDA | (107.1M) | (93.3M) | (29.7M) | (36.4M) | (67.9M) |
| D&A | 18.2M | 18.9M | 8.4M | 8.3M | 5.4M |
| EBIT | (125.3M) | (112.3M) | (38.1M) | (44.7M) | (73.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026